PATENT CLAIM ANALYSIS

Application Number: 16122015
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["514", "013500"]

Abstract:
Compositions and methods for the treatment and/or prevention of disorders associated with C1 esterase inhibitor deficienty are disclosed.

Claim (Index 17):
The lyophilized pharmaceutical composition of  claim 16 , wherein the lyophilized composition is reconstituted in sterile water to prepare a solution with a concentration of 500 U/mL of C1-esterase inhibitor.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15837969', '15837677', '15837938', '15837693', '14855168']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6864658102347557
- 35 USC 102 Novelty (BERT): 0.517301079258513
- Combined Prediction Score: 0.6695493371371315
- Mean Citation Score: 270.9834
- Max Citation Score: 275.21338
- Similarity Product: 199.5432895700812

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test